WARS1 and Sepsis: Further, we highlight the application of WARS1-neutralizing monoclonal antibody, simultaneously suppressing multiple proinflammatory cytokines and chemokines, as a promising therapy for preventing death in systemic severe hyperinflammatory sepsis.